Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.

GEN spoke with Milad Dagher, PhD, CEO and co-founder of Nomic, about how the nELISA platform is transforming proteomics. GEN: What are key factors influencing the broader adoption of proteomics ...

March 19, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a ...

Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) will likely be posting its quarterly earnings results before the market ...

Seattle's Nautilus Biotechnology is laying off 16% of workforce, and plans to release its commercial platform in late 2026.

In this feature, we explore the promise of next generation proteomics in modern healthcare and drug discovery.

Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT ...

[19] Therefore, improvements in the separation platform utilized in shotgun proteomics are reflected in easier peptide detection. In this way, shotgun proteomics covers the highest range of ...